- Home » News and Events
NEWS & EVENTS
NEWS & EVENTS
Our newest offerings and capabilities. Recent investments in network capacity, new and expanded services and expertise. Upcoming conferences and events.
Catalent Wins Scottish Engineering Vice President Award for Excellence
Oct 1, 2020
Catalent’s clinical supply site in Bathgate has won Scottish Engineering’s ‘Vice President Award 2020,’ recognising its continuous improvement programme in core values including “patient first, customer dedication, people, innovation, integrity and excellence.”
Modern Clinical Supply Strategies and Ensuring Effective Solutions to be Discussed by Catalent Experts at GCSG Virtual
Sep 15, 2020
Catalent today announced that it will lead multiple workshops and exhibit at the upcoming Global Clinical Supplies Group (GCSG) 2020 Global Virtual Conference, which takes place on Sept. 21-25, 2020.
Post-Brexit European Clinical Supply Solutions to be Discussed by Catalent at Upcoming Forum
Aug 11, 2020
Catalent today announced that Paul Ingram, Ph.D., Global Director, Strategic Development and Innovation, will present at the upcoming conference, ‘Clinical Trial Supply Forum’.
Catalent Completes Purchase of Pharmaceutical Clinical Packaging Facility in Shiga, Japan
Jul 1, 2020
Catalent today announced that it had completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility in Minakuchi, located in the Shiga prefecture of Japan.
Catalent Announces Acquisition of Japanese Facility to Provide Local and Global Clinical Supply Solutions
May 21, 2020
Catalent announced a deal to acquire a clinical packaging facility in Minakuchi, located in the Shiga prefecture of Japan, from Teva-Takeda Pharmaceuticals, Nagoya Aichi, Japan.
Proactive Strategies to Avoid Supply Delays to be Presented by Catalent at Outsourcing in Clinical Trials Virtual Conference
May 14, 2020
Catalent today announced that it will present at the upcoming conference, ‘Outsourcing in Clinical Trials 2020 – A Virtual Experience’.
Catalent Partners with Humanigen to Support FDA-Approved Phase 3 Lenzilumab Study for COVID-19
May 7, 2020
Catalent today welcomed the news by Humanigen, Inc., that it has dosed the first COVID-19 patient in its previously announced Phase 3 study for lenzilumab.
Strategies to Build Patient-Centric Clinical Supply Chains to be Presented by Catalent Experts at Upcoming Virtual Conferences
Apr 27, 2020
Catalent today announced that two of its experts will present at upcoming virtual industry conferences: CPhI North America Webinar Week; and Clinical Trial Supply 2020 – A Virtual Experience.
Catalent Receives RoSPA Silver Award for its Health and Safety Practices
Apr 8, 2020
Catalent today announced that it has been recognized by the Royal Society for the Prevention of Accidents for its health and safety practices, achieving a silver award for a second consecutive year.
CTS Europe
Date: March 24-25, 2021